Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T

Radiology

Volumn 263, Issue 1, 2012, Pages 64-76

  Bogner, Wolfgang ^a   Pinker Domenig, Katja ^a   Bickel, Hubert ^a   Chmelik, Marek ^a   Weber, Michael ^a   Helbich, Thomas H ^a   Trattnig, Siegfried ^a   Gruber, Stephan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; AREA UNDER THE CURVE; ARTICLE; ARTIFACT REDUCTION; BREAST CANCER; BREAST EXAMINATION; CLINICAL ARTICLE; CONTRAST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; GEOMETRIC DISTORTION; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LESION CONSPICUITY; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLOGICAL PARAMETERS; PHANTOM; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; READOUT SEGMENTED ECHO PLANAR IMAGING; REGION OF INTEREST; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SINGLE SHOT ECHO PLANAR IMAGING; TUMOR DIFFERENTIATION; ANALYSIS OF VARIANCE; BREAST TUMOR; IMAGE ENHANCEMENT; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; THREE DIMENSIONAL IMAGING;

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PHANTOMS, IMAGING; ROC CURVE; SENSITIVITY AND SPECIFICITY; SIGNAL-TO-NOISE RATIO;

EID: 84861314298     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12111494     Document Type: Article

References (50)

1. Bogner W, Gruber S, Pinker K, et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 2009;253(2):341-351.
2. El Khouli RH, Jacobs MA, Mezban SD, et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 2010;256(1):64-73.
3. Sinha S, Sinha U. Recent advances in breast MRI and MRS. NMR Biomed 2009;22(1):3-16.
4. Bartella L, Thakur SB, Morris EA, et al. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology 2007;245(1):80-87. (Pubitemid 47417790)
5. Gruber S, Debski BK, Pinker K, et al. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. Radiology 2011;261(3):752-761.
6. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007;244(2):381-388. (Pubitemid 47080869)
7. Pinker K, Grabner G, Bogner W, et al. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. Invest Radiol 2009;44(9):553-558.
8. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007;244(3):672-691. (Pubitemid 47292079)
9. Riedl CC, Ponhold L, Flöry D, et al. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 2007;13(20):6144-6152. (Pubitemid 350075074)
10. Costantini M, Belli P, Rinaldi P, et al. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol 2010;65(12):1005-2012.
11. Chen X, Li WL, Zhang YL, Wu Q, Guo YM, Bai ZL. Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. BMC Cancer 2010;10:693.
12. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16(2):172-178. (Pubitemid 34810055)
13. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7(1):23-29.
14. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007;17(10):2646-2655.
15. Wenkel E, Geppert C, Schulz-Wendtland R, et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 2007;14(9):1077-1083. (Pubitemid 47260686)
16. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005;29(5):644-649. (Pubitemid 41395779)
17. Iacconi C, Giannelli M, Marini C, et al. The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol 2010;20(2):303-308.
18. Kim H, Morgan DE, Zeng HD, et al. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology 2008;248(3):844-851.
19. Park SH, Moon WK, Cho N, et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 2010;257(1):56-63.
20. Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006;24(7):843-847. (Pubitemid 44205378)
21. Sharma U, Danishad KKA, Seenu V, Jagannathan NR. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009;22(1):104-113.
22. Porter DA, Calamante F, Gadian DG, Connelly A. The effect of residual Nyquist ghost in quantitative echo-planar diffusion imaging. Magn Reson Med 1999;42(2):385-392. (Pubitemid 29364718)
23. Kuroki Y, Nasu K, Kuroki S, et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004;3(2):79-85.
24. Porter DA, Heidemann RM. High resolution diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging and a two-dimensional navigator-based reacquisition. Magn Reson Med 2009;62(2):468-475.
25. Stadlbauer A, Bernt R, Gruber S, et al. Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions. Eur Radiol 2009;19(10):2349-2356.
26. Kinoshita T, Yashiro N, Ihara N, Funatu H, Fukuma E, Narita M. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002;26(6):1042-1046. (Pubitemid 36076728)
27. Baltzer PA, Renz DM, Herrmann KH, et al. Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol 2009;19(7):1612-1620.
28. Jin G, An N, Jacobs MA, Li K. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol 2010;17(4):456-463.
29. Matsuoka A, Minato M, Harada M, et al. Comparison of 3.0- and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 2008;26(1):15-20. (Pubitemid 351928143)
30. Porter DA, Mueller E. Multi-shot diffusion-weighted EPI with readout mosaic segmentation and 2D navigator correction [abstr]. In: Proceedings of the Twelfth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2004; 442.
31. Holdsworth SJ, Skare S, Newbould RD, Bammer R. Robust GRAPPA-accelerated diffusion-weighted readout-segmented (RS)-EPI. Magn Reson Med 2009;62(6):1629-1640.
32. Holdsworth SJ, Skare S, Newbould RD, Guzmann R, Blevins NH, Bammer R. Readout-segmented EPI for rapid high resolution diffusion imaging at 3 T. Eur J Radiol 2008;65(1):36-46.
33. Holdsworth SJ, Yeom K, Skare S, Gentles AJ, Barnes PD, Bammer R. Clinical application of readout-segmented- echo-planar imaging for diffusion-weighted imaging in pediatric brain. AJNR Am J Neuroradiol 2011;32(7):1274-1279.
34. Heidemann RM, Porter DA, Anwander A, et al. Diffusion imaging in humans at 7T using readout-segmented EPI and GRAPPA. Magn Reson Med 2010;64(1):9-14.
35. Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 2010;46(8):1296-1316.
36. Floery D, Helbich TH. MRI-guided percutaneous biopsy of breast lesions: materials, techniques, success rates, and management in patients with suspected radiologic-pathologic mismatch. Magn Reson Imaging Clin N Am 2006;14(3):411-425. (Pubitemid 46053834)
37. Partridge SC, McKinnon GC, Henry RG, Hylton NM. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging 2001;14(4):433-438. (Pubitemid 32906561)
38. Stejskal EO. Use of spin echoes in a pulsed magnetic-field gradient to study anisotropic restricted diffusion and flow. J Chem Phys 1965;43(10):3597-3603.
39. Park HW, Kim DJ, Cho ZH. Gradient reversal technique and its applications to chemical-shift-related NMR imaging. Magn Reson Med 1987;4(6):526-536. (Pubitemid 17112152)
40. Helbich TH. Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 2000;34(3):208-219. (Pubitemid 30601694)
41. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15(6):693-704. (Pubitemid 34606504)
42. Vincent RD, Janke A, Sled JG, Baghdadi L, Neelin P, Evans AC. MINC 2.0: a modality independent format for multidimensional medical images. Presented at the 11th Annual Meeting of the Organization for Human Brain Mapping, Toronto, Canada, June 12-16, 2005.
43. Kaufman L, Kramer DM, Crooks LE, Ortendahl DA. Measuring signal-to-noise ratios in MR imaging. Radiology 1989;173(1):265-267. (Pubitemid 19242443)
44. Pinker-Domenig K, Bogner W, Gruber S, et al. High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? Eur Radiol 2012;22(2):322-330.
45. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44(3):837-845.
46. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307-310. (Pubitemid 16134762)
47. Petralia G, Bonello L, Summers P, et al. Intraobserver and interobserver variability in the calculation of apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance imaging (DW-MRI) of breast tumours. Radiol Med 2011;116(3):466-476.
48. Wiesinger F, Van de Moortele PF, Adriany G, De Zanche N, Ugurbil K, Pruessmann KP. Parallel imaging performance as a function of field strength: an experimental investigation using electrodynamic scaling. Magn Reson Med 2004;52(5):953-964. (Pubitemid 39453268)
49. Deoni SCL. Transverse relaxation time (T2) mapping in the brain with off-resonance correction using phase-cycled steady-state free precession imaging. J Magn Reson Imaging 2009;30(2):411-417.
50. Rakow-Penner R, Daniel B, Yu HZ, Sawyer-Glover A, Glover GH. Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL. J Magn Reson Imaging 2006;23(1):87-91. (Pubitemid 43100723)